PC
GILD icon

Palo Capital’s Gilead Sciences GILD Stock Holding History

Palo Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,341
Closed -$1.61M – 127
2016
Q3 		$1.61M Sell
20,341
-15,017
-42% -$1.22M 1.12% 34
2016
Q2 		$2.95M Buy
35,358
+17,740
+101% +$1.57M 1.01% 34
2016
Q1 		$1.62M Buy
17,618
+2,113
+14% +$191K 1.28% 15
2015
Q4 		$1.57M Sell
15,505
-160
-1% -$16.6K 1.42% 13
2015
Q3 		$1.54M Buy
15,665
+860
+6% +$95.5K 1.34% 14
2015
Q2 		$1.73M Buy
14,805
+1,870
+14% +$204K 1.36% 15
2015
Q1 		$1.27M Buy
+12,935
New +$1.31M 1.04% 38

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palo Capital's GILD Position: Q4 2016 in Review

Palo Capital sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 20,341 shares — an estimated $1.61M sold.

Palo Capital first reported a position in GILD in Q1 2015 and held it in 7 quarters. The position peaked at $2.95M in Q2 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Palo Capital reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Palo Capital sold 20,341 Gilead Sciences shares in Q4 2016, an estimated $1.61M.
  • Palo Capital first reported a position in Gilead Sciences in Q1 2015 and held it in 7 quarters.
  • Palo Capital's Gilead Sciences position peaked at $2.95M in Q2 2016.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Palo Capital's 13F filing for Q4 2016, filed 18 Jan 2017.